Overview
Eleonora Pagan practices in Milan, Italy. Ms. Pagan is rated as an Experienced expert by MediFind in the treatment of Andersen-Tawil Syndrome. Her top areas of expertise are Long QT Syndrome, Breast Cancer, Triple-Negative Breast Cancer, Ventricular Fibrillation, and Mastectomy.
Her clinical research consists of co-authoring 67 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Andersen-Tawil Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerMs. Pagan isAdvanced. Learn about Breast Cancer.
- Long QT SyndromeMs. Pagan isAdvanced. Learn about Long QT Syndrome.
- MastectomyMs. Pagan isAdvanced. Learn about Mastectomy.
- Triple-Negative Breast CancerMs. Pagan isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- Adult Soft Tissue SarcomaMs. Pagan isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Andersen-Tawil SyndromeMs. Pagan isExperienced. Learn about Andersen-Tawil Syndrome.
- Autosomal Recessive HypotrichosisMs. Pagan isExperienced. Learn about Autosomal Recessive Hypotrichosis.
- Breast Cancer in MenMs. Pagan isExperienced. Learn about Breast Cancer in Men.
- Brugada SyndromeMs. Pagan isExperienced. Learn about Brugada Syndrome.
- Cardiac ArrestMs. Pagan isExperienced. Learn about Cardiac Arrest.